Prakiraan wutah bathi resik saben saham kanggo taun ngarep Oncternal (ONCT)

Logo korporat perusahaan Oncternal Therapeutics (ONCT)

EPS growth prospects for next year on the GURU.Markets terminal linear chart are based on Oncternal Therapeutics (ONCT) developing targeted therapies for rare leukemias, with the 0.00 parameter determining the metric's magnitude. However, the risk of late-stage trial failure and competition pose threats, while the closure of primary tests has led to asset mothballing and the consideration of the firm's liquidation.

Oncternal (ONCT): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 14.12.2024

Ringkesan rincian data analitis Oncternal (ONCT)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Oncternal Therapeutics
Produk dadi Oncternal Therapeutics Inc

This indicator measures the expected earnings per share (EPS) growth for the next period, reflecting the analysts' consensus forecast regarding the business's ability to scale profitability. In the context of developing targeted lymphoma therapies for Oncternal Therapeutics (ONCT), shifts in analysts' expectations for EPS n+1 growth demonstrate the impact of clinical successes on future capitalization, allowing for an assessment of the company's fundamental stability and asset quality.

Analisis pesaing Oncternal Therapeutics

INCY (incyte.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep hutch-med.com HCM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Corp (NUVB)|DAWN - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monopar Pharma MNPR|Inhibrx Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMAB - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Fennec Pharmaceuticals|HRTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Nuvectis NVCT|Prakiraan wutah bathi saben saham kanggo taun ngarep CHRS|Prakiraan wutah bathi resik saben saham ing taun ngarep Corbus Pharmaceuticals CRBP|Prakiraan wutah bathi saben saham kanggo taun ngarep CRDF (Cardiff Oncology Inc.)|BYSI (BeyondSpring) - Dinamika bathi saben saham sing diarepake ing taun ngarep|BioAtla - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep LIXT (Lixte Biotechnology Holdings, Inc.)|Citius Pharmaceuticals, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep CLRB (Cellectar)|BLRX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep canfite.com (CANF)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep aprea.com|KZIA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SLXN|Prakiraan wutah bathi kanggo taun ngarep NuCana PLC (NCNA)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Chimerix, Inc CMRX|CYCC (Cyclacel) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|GTHX: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kronos Bio Inc|Kintara Therapeutics Inc (KTRA) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PRTG (Portage Biotech Corp)